USF Health In the News – for the week of November 30, 2009
For the week of November 30, 2009 – a snapshot of our colleagues making news across the country and around the world
In what may one of the largest medication contracts in USF neurosciences, USF Health research team Paul Sanberg, PhD, DSc, and Douglas Shytle, PhD, retired USF psychiatry professor Archie Silver and former student Mary Newman, made international news with their USF patent for TC-5214. The drug holds promise for treatment resistant depression. Targacept Inc. and AstraZeneca PLC, one of the world’s largest drug makers, have struck a billion dollar deal to continue trials and try to bring the drug to market.
In other news the USF Health Smoke Free initiative received additional attention early in the week highlighting , Steven Specter, PhD, along with more mentions for the innovative Women in Surgery initiative led by Sharona Ross, MD. Faculty member Anna Giuliano, PhD, comments on new actions by the FDA regarding Gardasil, John Sinnott, MD, weighs in on the spread of MRSA and Lewis Rubin, MD, commented on the future of NICU design.
TELEVISION NEWS
You can access recent television news stories about USF Health here: Media Clips Gallery
PRINT & ONLINE NEWS
Click through the green headline to access the story
United Press International (in addition to more than 20 media worldwide including: FOXBusiness; Centre Daily Times; MSN Money; Webfinanser; Presskontakt.se; Euro Investor; dBusiness News Triangle; Genetic Engineering News)
…AstraZeneca under the agreement with respect to TC-5214 to the University of South Florida Research Foundation under the terms of an existing license…
St. Petersburg Times
Big drug development expected to bring millions to USF
“As the drug goes on the market, we will continue getting royalties,” Holbrook said. “This is the starting point. This is long-term gain. And that’s why I say this is a huge deal.”
Tampa Bay Business Journal
USF drug at center of $1 billion AstraZeneca, Targacept deal
A drug to treat depression that was created and patented by a team of University of South Florida researchers is poised to bring millions of dollars of royalties to the university.
Tampa Tribune
Big payoff expected for USF with licensing of new drug
Dr. Stephen Klasko, vice president for health sciences at USF, likened the impact of the deal to the spinoffs of a cancer drug and sports drink that helped establish the reputations of Florida’s best-known research universities.
Yahoo Finance (in addition to international sites: Web Wire, Bio Space, Pharma Deals, Centre Daily, Euro Investor and Device Space)
AstraZeneca and Targacept Form Global Collaboration
Targacept would be required to pay a percentage of amounts received from AstraZeneca under the agreement with respect to TC-5214 to the University of South Florida Research Foundation under the terms of an existing license agreement.
Tampa Tribune (Tobacco.org; Individual.com)
At USF Health, “we’re trying to deal with it in a humane and positive manner,” said Steven Specter, USF associate dean for student affairs in the College of Medicine.
Tampa Bay Business Journal
Hot Leads; Startups, expansions, moves and new products and services
The University of South Florida launched its Women in Surgery Initiative in Tampa. It is the first professional and academic organization in Tampa focusing on women seeking careers in surgery,…
Advance for Respiratory Care & Sleep Medicine
“That’s undergone a major sea change,” said Lewis P. Rubin, MD, chief of neonatology at Tampa General Hospital and University of South Florida in Tampa, Fla.
St. Petersburg Times
Cancer screening debate points to the political power of the breast
Dr. Sarah Eisen, a 27-year-old surgical resident at the University of South Florida, who has worked with patients facing mastectomies.
Pharmacy Choice
Gardasil approved for use in males Cervarix gets OK for use in females
…Anna Giuliano, PhD, professor of medicine and epidemiology at the University of South Florida and a program leader in the Risk Assessment,…
Tampa Tribune
USF Health Alzheimer’s Center will present Alzheimer’s Disease: What Caregivers Need…
St. Petersburg Times
Knowing symptoms of MRSA infection can be key in treating superbug
…overblown,” says Dr. John Sinnott, director of infectious disease at the University of South Florida and Tampa General Hospital. “It could be brought into…
WWSB, ABC 7 Sarasota – mysuncoast.com
Web surf to save your aging brain
…learning would help,” said Paul Sanberg, director of the University of South Florida Center of Excellence for Aging and Brain Repair in Tampa .
Zikkir
From concept to clinical trial: A translational research story
…Ashok Raj and Dr. Chuanhai Cao are part of a multidisciplinary USF Health team investigating how GCSF reverses Alzheimer’s pathology.
Orth SuperSite
Extraskeletal Myxoid Chondrosarcoma: Rare Presentation in the Knee Joint Space
Drs Alexander and Henderson are from the Department of Orthopedics and Sports Medicine, University of South Florida, Tampa, Ms Rodriguez is from the …
Bio-Medicine
Immune system ‘escape hatch’ gives cancer cells traction
…’escape hatch’ gives cancer cells traction research initially conducted at the University of South Florida where …Using chemical tests in which…
Florida Today
Hospitals will get heart data in Bluetooth
Dr. Joel Strom, a cardiac expert and a professor of internal medicine at the University of South Florida, said the goal is to reduce “door-to-balloon time”
News Blaze (Webfinanser; My News Desk; PR.com; Enhanced Online News)
BodyLogicMD is Focus of Florida Trend’s December Cover Story
The University of South Florida’s College of Medicine in Tampa is home to North America’s only program designed for anti aging physicians.
****All content is provided to the USF Health Office of Communications from our media monitoring service, Meltwater News. Meltwater News monitors and analyzes online news in more than 110 countries searching over 90,000 global news sources for relevant keywords related to the University of South Florida and USF Health.
